Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

61.19
+0.75001.24%
Volume:195.48K
Turnover:11.86M
Market Cap:1.75B
PE:156.90
High:61.54
Open:60.49
Low:59.89
Close:60.44
52wk High:66.37
52wk Low:14.27
Shares:28.58M
Float Shares:26.78M
Volume Ratio:0.58
T/O Rate:0.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:37.54
PE(LYR):-357.86

Loading ...

Eton Pharma Submits FDA Supplement to Expand Khindivi Label to Younger Pediatric Patients

Reuters
·
Jul 29

Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of Khindivi® (Hydrocortisone) Oral Solution

THOMSON REUTERS
·
Jul 29

Eton Pharmaceuticals is Maintained at Buy by Craig-Hallum

Dow Jones
·
Jul 29

Eton Pharmaceuticals price target raised to $62 from $40 at Craig-Hallum

TIPRANKS
·
Jul 28

Eton Pharmaceuticals (ETON) Stock Looks Overvalued Even After Recent Wins

Simply Wall St.
·
Jul 18

Eton Pharmaceuticals Initiated at Buy by Canaccord Genuity

Dow Jones
·
Jul 17

Opaleye Management Disposes of 28,315 Eton Pharma Shares Worth $1.06 Million

Reuters
·
Jul 17

Eton Pharmaceuticals initiated with a Buy at Canaccord

TIPRANKS
·
Jul 17

Opaleye Management Sells 126,685 Eton Pharma Shares for $4.8 Million

Reuters
·
Jul 08

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON), Tarsus Pharmaceuticals (TARS) and Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jul 06

Analysts’ Top Healthcare Picks: Eton Pharmaceuticals (ETON), Arrowhead Pharmaceuticals (ARWR)

TIPRANKS
·
Jun 27

Eton Pharma director Jennifer McKie Adams disposes of 50,000 common shares for $1.62 million

Reuters
·
Jun 18

Eton Pharmaceuticals shareholders elect two directors at annual meeting

Reuters
·
Jun 10

Eton Pharma CFO Judith Matthews files initial beneficial ownership statement

Reuters
·
Jun 02

Eton Pharma CEO Sean Brynjelsen sells common shares worth $3.87 million

Reuters
·
May 30

Eton Pharma Chief Business Officer David Krempa disposes of 99,999 common shares worth USD 3.24 million

Reuters
·
May 28

Analysts Are Bullish on These Healthcare Stocks: Personalis (PSNL), Eton Pharmaceuticals (ETON)

TIPRANKS
·
May 22

Eton Pharmaceuticals secures US commercialization rights to leishmaniasis drug Impavido

Reuters
·
May 20

Eton Pharmaceuticals Inc - Exclusive U.S. Commercialization Rights to Impavido Effective September 26, 2026

THOMSON REUTERS
·
May 20

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to Impavido® (Miltefosine)

THOMSON REUTERS
·
May 20